Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Technology
RYAN DEFFENBAUGH

Confluent Stock Jumps On Sales, Earnings Beat For Data Software Player

Data software company Confluent late Tuesday reported first-quarter earnings and sales that exceeded expectations. Confluent stock jumped in late trading.

The Mountain View, Calif.-based company said that it earned an adjusted 5 cents per share on sales of $217 million for the March-ended quarter. On average, analysts projected Confluent would post adjusted earnings of 2 cents per share on sales of $211.6 million, according to FactSet.

Sales increased 25% from the same quarter a year earlier. Earnings, meanwhile, swung from an adjusted loss of 9 cents per share for the first quarter in 2023.

For the current quarter, Confluent guided for sales of $229.5 million. Analysts were projecting Confluent would tally $228.7 million in sales for the June-ending quarter, according to FactSet.

On the stock market today, Confluent stock is up more than 6% at 29.54 in recent after-hours action.

Confluent Cloud Business Grows

Confluent offers what is known as data streaming software, which it describes as a central nervous system for an enterprise's data. The company has the attention of some investors as an artificial intelligence play. Its software is utilized by a list of firms that includes OpenAI to help move and sort data in real-time.

In its news release, the company highlighted the growth of its Confluent Cloud subscription product. Confluent Cloud revenue grew 45% year over year to $107 million in the first quarter.

Confluent Cloud "now accounts for the majority of our subscription revenue and remains our fastest growing offering," Chief Executive Jay Kreps said in a news release. "These results show the critical role data streaming plays in the modern technology landscape."

Confluent Stock: Technical Ratings

Prior to earnings, Confluent stock fell 2.7% in Tuesday trading. Shares have gained 19% this year compared to an 8.8% gain for the S&P 500. Confluent stock is up 22.8% in the past 12 months, compared to a 25% gain for the S&P 500.

Coming into the report, Confluent stock had an IBD Composite Rating of 98 out of a best-possible 99, according to IBD Stock Checkup. The score combines five separate proprietary ratings into one rating. The best growth stocks have a Composite Rating of 90 or better.

Further, Confluent's IBD Relative Strength Rating was 85 out of 99.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.